CUSIP

Root, Inc. Announces 2022 Second Quarter Results; Moving Forward with Reverse Stock Split at 1-for-18 Ratio

Retrieved on: 
Monday, August 8, 2022 - 9:17pm

Roots second quarter results and management commentary can be found by accessing the shareholder letter posted to the companys investor relations website at ir.joinroot.com .

Key Points: 
  • Roots second quarter results and management commentary can be found by accessing the shareholder letter posted to the companys investor relations website at ir.joinroot.com .
  • Webcast and Conference Call Details:
    Additionally, Root announced today that it will proceed with a 1-for-18 reverse stock split previously approved by Root stockholders at the annual meeting of shareholders on June 7, 2022.
  • No fractional shares will be issued in connection with the reverse stock split.
  • Additional information concerning the reverse stock split can be found in Roots definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2022.

Kimco Realty® Announces Redemption in Full of its 3.375% Notes due 2022

Retrieved on: 
Monday, August 8, 2022 - 9:07pm

Kimco Realty (NYSE: KIM) (Kimco Realty or the Company), today announced that it will redeem $288.402 million aggregate principal amount of its 3.375% Notes due October 15, 2022 (CUSIP No.

Key Points: 
  • Kimco Realty (NYSE: KIM) (Kimco Realty or the Company), today announced that it will redeem $288.402 million aggregate principal amount of its 3.375% Notes due October 15, 2022 (CUSIP No.
  • 948741 AH6) (the Senior Notes), representing all of the outstanding Senior Notes, on September 7, 2022 (the Redemption Date).
  • Pursuant to the terms of the Senior Notes, the redemption price (the Redemption Price) will be equal to par, plus accrued and unpaid interest to, but not including, the Redemption Date of $16.125 for each $1,000 principal amount of Senior Notes redeemed.
  • A notice of redemption and related materials will be mailed to holders of record of the Senior Notes on August 8, 2022.

Lumen Announces Early Tender Results

Retrieved on: 
Saturday, August 6, 2022 - 2:11am

(4) Includes the Maximum Tender Early Tender Premium (as defined in the Offer to Purchase and Solicitation Statement) for Notes validly tendered prior to the Early Tender Date (and not validly withdrawn) and accepted for purchase by the applicable offeror.

Key Points: 
  • (4) Includes the Maximum Tender Early Tender Premium (as defined in the Offer to Purchase and Solicitation Statement) for Notes validly tendered prior to the Early Tender Date (and not validly withdrawn) and accepted for purchase by the applicable offeror.
  • (5) As further described in the Offer to Purchase and Solicitation Statement, the Lumen Notes are also subject to the Series Tender Cap of $350,000,000.
  • Because the aggregate principal amount of Maximum Tender Notes validly tendered (and not validly withdrawn) at or prior to the Early Tender Date did not exceed the Aggregate Maximum Tender Amount or the Series Tender Cap, the applicable offeror intends to purchase all of the Maximum Tender Notes validly tendered (and not validly withdrawn) at or prior to the Early Tender Date on the terms described below.
  • Lumen and Lumen Technologies are registered trademarks of Lumen Technologies LLC in the United States.

IMAC Holdings, Inc. Announces NASDAQ Ticker Symbol Change from “IMAC” to “BACK”

Retrieved on: 
Wednesday, August 3, 2022 - 2:22pm

BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc.(Nasdaq:IMAC) (IMAC or the Company), will change its ticker symbol on the NASDAQ Stock Exchange from IMAC to BACK at the open of market trading on Monday, August 8, 2022.

Key Points: 
  • BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc.(Nasdaq:IMAC) (IMAC or the Company), will change its ticker symbol on the NASDAQ Stock Exchange from IMAC to BACK at the open of market trading on Monday, August 8, 2022.
  • The spine is your bodys central support structure and we recognize its importance for your overall health.
  • We believe that changing our symbol to BACK provides greater recognition of our services and vision for assisting with optimal spinal health and whole-body wellness.
  • No action by the company's shareholders is required with respect to the symbol change.

Unum Group Enters into Term Loan Facility and Announces Redemption of 4.000% Senior Notes due 2024

Retrieved on: 
Tuesday, August 2, 2022 - 7:30pm

The net proceeds from the term loan facility, together with cash on hand, are expected to be used to redeem all of the company's 4.000 percent senior notes due 2024 (CUSIP Number 91529Y AK2) (the "2024 Notes") outstanding on September 1, 2022 (the "Redemption Date").

Key Points: 
  • The net proceeds from the term loan facility, together with cash on hand, are expected to be used to redeem all of the company's 4.000 percent senior notes due 2024 (CUSIP Number 91529Y AK2) (the "2024 Notes") outstanding on September 1, 2022 (the "Redemption Date").
  • PNC Capital Markets LLC and Truist Securities, Inc. jointly arranged the financing of the term loan facility.
  • The company has instructed The Bank of New York Mellon Trust Company, N.A., the trustee and paying agent for the 2024 Notes, to distribute a notice of redemption to all registered holders of the 2024 Notes.
  • The 2024 Notes must be surrendered to The Bank of New York Mellon Trust Company, N.A., to collect the redemption price pursuant to the notice of redemption.

HAVN Life Announces a 30:1 Consolidation of its Common Shares

Retrieved on: 
Friday, July 29, 2022 - 9:30pm

VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN ) (OTC: HAVLF ) (FSE: 5NP ) (the "Company or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it will complete a consolidation (Consolidation) of its issued and outstanding common shares on the basis of one (1) post-consolidation common share for every thirty (30) pre-Consolidation common shares.

Key Points: 
  • VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN ) (OTC: HAVLF ) (FSE: 5NP ) (the "Company or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it will complete a consolidation (Consolidation) of its issued and outstanding common shares on the basis of one (1) post-consolidation common share for every thirty (30) pre-Consolidation common shares.
  • Fractional interests of 0.5 or greater will be rounded up to the nearest whole number of Common Shares and fractional interests of less than 0.5 will be rounded down to the nearest whole number of Common Shares.
  • As a result of the Consolidation, the outstanding common shares of the Company will be reduced to 5,109,665.
  • The common shares will begin trading on a consolidated basis and with a new CUSIP number on August 3, 2022.

Zions Bancorporation’s Board Approves Share Repurchase and Declares Dividends on Common and Preferred Stock

Retrieved on: 
Friday, July 29, 2022 - 7:06pm

(NASDAQ: ZION) announced today that its board of directors (board) authorized a share repurchase for the third quarter of 2022 of up to $50 million.

Key Points: 
  • (NASDAQ: ZION) announced today that its board of directors (board) authorized a share repurchase for the third quarter of 2022 of up to $50 million.
  • The board also declared a regular quarterly dividend of $0.41 per common share, payable August 25, 2022, to shareholders of record at the close of business on August 18, 2022.
  • Additionally, the board declared regular quarterly cash dividends on the company's various perpetual preferred shares, as detailed below.
  • Zions has obtained the requisite regulatory approval to allow Zions to timely execute on this authorization.

McEwen Mining: Reverse Split To Be Effective July 28th

Retrieved on: 
Wednesday, July 27, 2022 - 9:16pm

Following effectiveness of the Reverse Split the Company expects to regain compliance with NYSE continued listing requirements and remain listed on the NYSE.

Key Points: 
  • Following effectiveness of the Reverse Split the Company expects to regain compliance with NYSE continued listing requirements and remain listed on the NYSE.
  • As previously reported, no fractional shares will be issued in connection with the Reverse Split.
  • Except for any shareholders who receive cash in lieu of a fractional share as a result of the Reverse Split, the Reverse Split will affect all shareholders uniformly.
  • Computershare Trust Company, N.A., the Companys transfer agent, is acting as the exchange agent for the Reverse Split.

UMH PROPERTIES, INC. COMPLETES ITS REDEMPTION OF ITS SERIES C PREFERRED STOCK

Retrieved on: 
Tuesday, July 26, 2022 - 9:15pm

FREEHOLD, NJ, July 26, 2022 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) today announced that on July 26, 2022, it completed its previously announced redemption of all 9,884,000 issued and outstanding shares of its 6.75% Series C Cumulative Redeemable Preferred Stock (the Series C Preferred Stock) (CUSIP 903002400).

Key Points: 
  • FREEHOLD, NJ, July 26, 2022 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) today announced that on July 26, 2022, it completed its previously announced redemption of all 9,884,000 issued and outstanding shares of its 6.75% Series C Cumulative Redeemable Preferred Stock (the Series C Preferred Stock) (CUSIP 903002400).
  • Samuel A. Landy, President and Chief Executive Officer, commented, "UMH is pleased to announce our completion of the redemption of our Series C Preferred Stock.
  • The redemption will decrease our cost of capital and should increase our Funds from Operations (FFO) and earnings for shareholders.
  • UMH also has an ownership interest in and operates one community in Florida, containing 219 sites, through its joint venture with Nuveen Real Estate.

Lumen Announces Cash Tender Offers and Consent Solicitations

Retrieved on: 
Tuesday, July 26, 2022 - 12:55am

Subject to the Aggregate Maximum Tender Amount, the Series Tender Cap and proration and the satisfaction or waiver of the conditions to the Tender Offers and the Consent Solicitations, including the Divestiture Condition, with respect to the applicable offeror, all Maximum Tender Notes tendered at or before the Early Tender Date having a higher Acceptance Priority Level will be accepted before any Maximum Tender Notes tendered at or before the Early Tender Date having a lower Acceptance Priority Level are accepted, and all Maximum Tender Notes validly tendered after the Early Tender Date having a higher Acceptance Priority Level will be accepted before any Maximum Tender Notes tendered after the Early Tender Date having a lower Acceptance Priority Level are accepted in the Maximum Tender Offers.

Key Points: 
  • Subject to the Aggregate Maximum Tender Amount, the Series Tender Cap and proration and the satisfaction or waiver of the conditions to the Tender Offers and the Consent Solicitations, including the Divestiture Condition, with respect to the applicable offeror, all Maximum Tender Notes tendered at or before the Early Tender Date having a higher Acceptance Priority Level will be accepted before any Maximum Tender Notes tendered at or before the Early Tender Date having a lower Acceptance Priority Level are accepted, and all Maximum Tender Notes validly tendered after the Early Tender Date having a higher Acceptance Priority Level will be accepted before any Maximum Tender Notes tendered after the Early Tender Date having a lower Acceptance Priority Level are accepted in the Maximum Tender Offers.
  • However, if the Maximum Tender Offers are not fully subscribed as of the Early Tender Date, Maximum Tender Notes tendered at or before the Early Tender Date will be accepted for purchase in priority to other Maximum Tender Notes validly tendered after the Early Tender Date, even if such Maximum Tender Notes tendered after the Early Tender Date have a higher Acceptance Priority Level than Maximum Tender Notes tendered prior to the Early Tender Date, in all cases as further described in the Offer to Purchase and Consent Solicitation Statement.
  • Holders of the Notes are encouraged to read the Offer to Purchase and Consent Solicitation Statement, as it contains important information regarding the Tender Offers and the Consent Solicitations.
  • The Tender Offers and the Consent Solicitations are only being made pursuant to the Offer to Purchase and Consent Solicitation Statement.